electroCore News

Analysts Have Conflicting Sentiments on These Healthcare Companies: Electrocore (ECOR), Disc Medicine (IRON) and Allakos (ALLK)

TipRanksMay 10 07:10

Electrocore's Strong Q1 Performance and Growth Potential Affirm Buy Rating

TipRanksMay 10 07:10

Earnings Call Summary | ElectroCore(ECOR.US) Q1 2024 Earnings Conference

The following is a summary of the ElectroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript:Financial Performance:ElectroCore reported a sixth consecutive record revenue quarter of $5.4 million for Q1

Futu NewsMay 9 08:32 · Conference Call

Electrocore: Strong Financials and Market Penetration Justify Buy Rating With $15 Target

TipRanksMay 9 05:45

electroCore | 10-Q: Quarterly report

Futu NewsMay 8 16:13 · Announcements

ElectroCore Q1 2024 GAAP EPS $(0.53) Beats $(0.61) Estimate, Sales $5.443M Beat $4.767M Estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) by 13.11 percent. This is a 57.26 percent increase over losses of $(1.24)

BenzingaMay 8 15:58

Earnings Flash (ECOR) ELECTROCORE Posts Q1 Revenue $5.4M, Vs. Street Est of $4.8M

04:12 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (ECOR) ELECTROCORE Posts Q1 Revenue $5.4M, vs. Street Est of $4.8M

MT NewswiresMay 8 15:12

Press Release: ElectroCore Announces First Quarter 2024 Financial Results

electroCore Announces First Quarter 2024 Financial Results Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023 Company to host a conference call and webca

Dow JonesMay 8 15:05

ElectroCore 1Q Sales $5.44M >ECOR

ElectroCore 1Q Sales $5.44M >ECOR

Dow JonesMay 8 15:05

ElectroCore 1Q Loss/Shr 53c >ECOR

ElectroCore 1Q Loss/Shr 53c >ECOR

Dow JonesMay 8 15:05

ElectroCore 1Q Loss $3.51M >ECOR

ElectroCore 1Q Loss $3.51M >ECOR

Dow JonesMay 8 15:05

ElectroCore Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff

GlobeNewswireMay 3 15:05

ElectroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Globe NewswireMay 1 07:04

Truvaga Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

Globe NewswireApr 30 07:00

ElectroCore Announces the Launch of Truvaga Plus for General Wellness

ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile

GlobeNewswireApr 8 07:30

Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)

TipRanksMar 15 06:40

Electrocore's Battle With Cyber Threats: Protecting Sensitive Data Amidst Rising Security Risks

TipRanksMar 15 01:02

HC Wainwright & Co. Reiterates Buy on ElectroCore, Maintains $15 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore with a Buy and maintains $15 price target.

Analyst UpgradesMar 14 05:52

Electrocore's Growth Trajectory: A Buy Rating With Promising Prospects

TipRanksMar 14 05:27

Earnings Call Summary | ElectroCore(ECOR.US) Q4 2023 Earnings Conference

The following is a summary of the ElectroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript:Financial Performance:ElectroCore reported a significant increase in annual revenue in 2023, growing by 87%

Futu NewsMar 13 20:44 · Conference Call